CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...